[The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain] (Q79187583)
Jump to navigation
Jump to search
scientific article published on 01 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain] |
scientific article published on 01 October 2006 |
Statements
[The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain] (English)
P Lázaro y de Mercado
J Figueras Aloy
E Doménech Martínez
I Echániz Urcelay
R Closa Monasterolo
M A Wood Wood